Emblem Corp. (fka EMMBF)

[lbcb123]

Outstanding shares went up. Changes profit/loss per share. Also, their fixed expenses go up as they build out their distribution network.

One of the hardest things about finding a promising company is the necessary evil of diluting to raise cash through their research & development stage.

Emblem has dropped a lot as they diluted to raise around $100M cash. They still had $80M cash last quarter. The hard part is done. If you started buying anywhere near these prices instead of much higher, you are golden!

This is the real deal. The dilution is done with the exception of warrants that will be exercised at twice the current price. They deserve to make some cash for their earlier belief in the prospects here. Risk is deserving of future reward.

This isn't a "fluff" company trying to pump every successful bowel movement. It is a little frustrating as they (only) continue to execute their business plan while not communicating all their progress to the investment community. They know the best is yet to come.

This isn't a true cannabis play. They are more of a pharmaceutical company that is taking advantage of the adult recreational market for the optics of it and the chance to fund their future priorities.

John Stewart (Mr. Opioid) is determined to show the world that cannabis is a relevant alternative for a large percentage of patients and it is exciting to watch the business model take shape.

I have done a ton of research and have a lot of in the weeds knowledge. I will be happy to answer any questions, but for now just understand that this is a rare opportunity that is flying under the radar for now. Another quarter or two and it will be more clear what the potential is here!